Anne Roussin

1.1k total citations
42 papers, 696 citations indexed

About

Anne Roussin is a scholar working on Public Health, Environmental and Occupational Health, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Anne Roussin has authored 42 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 10 papers in Cellular and Molecular Neuroscience and 9 papers in Molecular Biology. Recurrent topics in Anne Roussin's work include Opioid Use Disorder Treatment (15 papers), Neuropeptides and Animal Physiology (8 papers) and Veterinary Pharmacology and Anesthesia (7 papers). Anne Roussin is often cited by papers focused on Opioid Use Disorder Treatment (15 papers), Neuropeptides and Animal Physiology (8 papers) and Veterinary Pharmacology and Anesthesia (7 papers). Anne Roussin collaborates with scholars based in France, United Kingdom and Laos. Anne Roussin's co-authors include Maryse Lapeyre‐Mestre, Jean‐Marie Zajac, Jean‐Louis Montastruc, Isabelle Quelven, Honoré Mazarguil, François Montastruc, Odile Burlet‐Schiltz, Laure Pourcel, Bernard Francès and Jean‐Philippe Raynaud and has published in prestigious journals such as PLoS ONE, Brain Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Anne Roussin

38 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Roussin France 16 219 167 146 102 102 42 696
Ryan K. Lanier United States 14 81 0.4× 82 0.5× 122 0.8× 25 0.2× 92 0.9× 29 488
Andrew J. Byrne United States 15 76 0.3× 52 0.3× 167 1.1× 21 0.2× 100 1.0× 62 857
Judith C. Kando United States 15 99 0.5× 68 0.4× 79 0.5× 18 0.2× 9 0.1× 40 1.2k
William S. John United States 13 223 1.0× 121 0.7× 185 1.3× 2 0.0× 40 0.4× 25 565
Mohamed A. Khalil Egypt 11 37 0.2× 53 0.3× 118 0.8× 6 0.1× 91 0.9× 46 637
Jan Fawcett United States 13 71 0.3× 29 0.2× 104 0.7× 37 0.4× 22 0.2× 16 739
M J Kreek United States 14 499 2.3× 276 1.7× 150 1.0× 6 0.1× 48 0.5× 26 943
Harry Ahdieh United States 19 42 0.2× 36 0.2× 391 2.7× 147 1.4× 571 5.6× 30 1.1k
Rutger van der Schrier Netherlands 12 89 0.4× 98 0.6× 114 0.8× 3 0.0× 145 1.4× 31 529
MarkS. Gold United States 6 323 1.5× 212 1.3× 79 0.5× 7 0.1× 58 0.6× 7 604

Countries citing papers authored by Anne Roussin

Since Specialization
Citations

This map shows the geographic impact of Anne Roussin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Roussin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Roussin more than expected).

Fields of papers citing papers by Anne Roussin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Roussin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Roussin. The network helps show where Anne Roussin may publish in the future.

Co-authorship network of co-authors of Anne Roussin

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Roussin. A scholar is included among the top collaborators of Anne Roussin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Roussin. Anne Roussin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roussin, Anne, et al.. (2025). First episode of catatonia followed by a psychotic episode related to chronic nitrous oxide use: A case report. Drug and Alcohol Review. 44(3). 908–912. 1 indexed citations
2.
Jouanjus, Émilie, et al.. (2024). Hypoglycémie profonde fatale dans un contexte d’abus de tramadol en milieu festif. Therapies. 79(6). 746–746.
3.
Lapeyre‐Mestre, Maryse, et al.. (2024). Monitoring opioid analgesic misuse, abuse and dependence: What to the data from addictovigilance tell us about the situation in France?. Therapies. 80(2). 241–251. 1 indexed citations
4.
Batisse, Anne, et al.. (2024). Pratique du chemsex en France : actualisation des données d’addictovigilance. Psychotropes. Vol. 30(2). 37–52.
5.
Roussin, Anne, et al.. (2024). Low-dose ketamine infusion to facilitate opioid tapering in chronic non-cancer pain with opioid-use disorder: a historical cohort study. Regional Anesthesia & Pain Medicine. 50(5). 421–428. 3 indexed citations
6.
Frauger, Élisabeth, Clémence Lacroix, Amélie Daveluy, et al.. (2023). Augmentation des surdoses et décès en lien avec la consommation de méthadone durant la crise sanitaire liée au COVID-19 en 2020. Therapies. 79(3). 297–306. 2 indexed citations
7.
Delage, Noémie, Bruno Pereira, Christian Dualé, et al.. (2022). Transcultural validation of a French–European version of the Prescription Opioid Misuse Index Scale (POMI-5F). Canadian Journal of Anesthesia/Journal canadien d anesthésie. 69(8). 1042–1052. 3 indexed citations
8.
Gérardin, Marie, Morgane Rousselet, A. Masseau, et al.. (2021). Descriptive analysis of sickle cell patients living in France: The PHEDRE cross-sectional study. PLoS ONE. 16(3). e0248649–e0248649. 3 indexed citations
9.
Montastruc, Jean‐Louis, et al.. (2020). Role of serotonin and norepinephrine transporters in antidepressant-induced arterial hypertension: a pharmacoepidemiological-pharmacodynamic study. European Journal of Clinical Pharmacology. 76(9). 1321–1327. 13 indexed citations
10.
Moulédous, Lionel, Stella Manta, Claire Rampon, et al.. (2019). Lack of correlation between the activity of the mesolimbic dopaminergic system and the rewarding properties of pregabalin in mouse. Psychopharmacology. 236(7). 2069–2082. 14 indexed citations
11.
Jouanjus, Émilie, Maryse Lapeyre‐Mestre, Anne Roussin, et al.. (2019). Teaching Basic Knowledge on Substance Use Disorders: The Impact of e-Learning on Health Professionals. Clinical Therapeutics. 41(10). 2154–2161. 1 indexed citations
12.
13.
Roussin, Anne, et al.. (2017). Overview of Pharmacovigilance System in Vietnam: Lessons Learned in a Resource-Restricted Country. Drug Safety. 41(2). 151–159. 14 indexed citations
14.
Caillet, Céline, Myriam Malet‐Martino, Agnès Sommet, et al.. (2016). Adverse drug reaction-related hospitalizations of adults in the Lao People's Democratic Republic: health risks of unknown medicines. Fundamental and Clinical Pharmacology. 30. 10–10. 3 indexed citations
15.
Caillet, Céline, Lamphone Syhakhang, Cyrille Delpierre, et al.. (2015). Population awareness of risks related to medicinal product use in Vientiane Capital, Lao PDR: a cross-sectional study for public health improvement in low and middle income countries. BMC Public Health. 15(1). 590–590. 6 indexed citations
16.
17.
Bounes, Vincent, Émilie Jouanjus, Anne Roussin, & Maryse Lapeyre‐Mestre. (2013). Acute pain management for patients under opioid maintenance treatment. European Journal of Emergency Medicine. 21(1). 1–1. 9 indexed citations
18.
Orriols, Ludivine, et al.. (2009). Evaluation of Abuse and Dependence on Drugs Used for Self-Medication. Drug Safety. 32(10). 859–873. 40 indexed citations
19.
Gelot, Agathe, et al.. (1998). Anti-opioid efficacy of Neuropeptide FF in morphine-tolerant mice. Brain Research. 808(2). 166–173. 29 indexed citations
20.
Roussin, Anne, et al.. (1992). Coupling of microdialysis with capillary electrophoresis: a new approach to the study of drug transfer between two compartments of the body in freely moving rats. Journal of Chromatography B Biomedical Sciences and Applications. 581(2). 257–266. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryan K. Lanier Breakdown of academic impact, for papers by Andrew J. Byrne Breakdown of academic impact, for papers by Judith C. Kando Breakdown of academic impact, for papers by William S. John Breakdown of academic impact, for papers by Mohamed A. Khalil Breakdown of academic impact, for papers by Jan Fawcett Breakdown of academic impact, for papers by M J Kreek Breakdown of academic impact, for papers by Harry Ahdieh Breakdown of academic impact, for papers by Rutger van der Schrier Breakdown of academic impact, for papers by MarkS. Gold
Rankless by CCL
2026